Small-Molecule Drugs
Methylthioninium chloride
Also known as Methylene blue
Last reviewed: 2026-11-19
Evidence status & limitations
Approval for acquired methemoglobinemia is not proof of broad neurological or longevity effects.
Regulatory status
FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.
ProvayBlue · Methemoglobinemia
Acquired methemoglobinemia in pediatric and adult patients.
Authoritative label record
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextKnown risks & open questions
Serotonin syndrome interactions and hemolysis in G6PD deficiency are important documented risks.
Key sources
Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.
Related compounds
- Apomorphine
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Finasteride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Metformin
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Minoxidil
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Omeprazole
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications